Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 385

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 385
---
the “Non -423Component”), under which options shall be granted pursuant to rules, procedures or sub -plansdesigned to achieve tax, securities laws or other objectives for eligible employees, New Profusa and participating subsidiaries. Description of the ESPP The following description is qualified in its entirety by reference to the plan document, a copy of which is attached as Annex D to this proxy statement/consent solicitation statement/prospectus and incorporated into this proxy statement/consent solicitation statement/prospectus by reference. Administration The ESPP will be administered by the compensation committee of the New Profusa Board (the “Compensation Committee”). The Compensation Committee has the discretionary authority to do everything necessary and appropriate to administer the ESPP, including, without limitation, interpreting the provisions of the ESPP. All actions, decisions and determinations of, and interpretations by the Compensation Committee with respect to the ESPP will be final and binding upon all participants. Available Shares If the ESPP is approved, up to 330,020shares of New Profusa Common Stock, subject to adjustment for stock splits, stock dividends or other changes in New Profusa’s capital stock, will be reserved for issuance under the ESPP. Subject to the capitalization adjustment provisions included in the ESPP, the maximum number of shares which shall be made available for sale under the ESPP will automatically increase on the first day of each fiscal year, beginning immediately following the fiscal year ending December 31, 2025, and continuing until (and including) the fiscal year ending December 31, 2035, with such annual increase equal to 4% of the number of shares issued and outstanding on December 31 of the immediately preceding fiscal year, and (iii) an amount determined by the New Profusa Board. If, on a given exercise date, the number of shares with respect to which options are to be exercised exceeds the number of shares then available under the ESPP, the Compensation Committee will make a pro rata allocation of the shares remaining available for purchase in as uniform a manner as shall be practicable and as it shall determine to be equitable. As of May13, 2025, the closing price for a share of NorthView Common Stock was $12.10 per share. Merger or Asset Sale In the event of a proposed sale of all or substantially all of the assets of New Profusa, or the merger of New Profusa with or into another corporation, each outstanding option shall be assumed or an equivalent option substituted by the successor corporation or a